Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Yu-Qing
NCT05703750: Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)	Recruiting	N/A	228	RoW	TACE ± Systemic therapy	Zhongda Hospital	Hepatocellular Carcinoma, Portal Hypertension	06/23	12/23
NCT05704192: CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)	Recruiting	N/A	373	RoW	TACE ± Systemic therapy	Zhongda Hospital	Hepatocellular Carcinoma, Portal Hypertension	06/23	12/23